MENTOR, OHIO – March 25, 2024 – STERIS today announced the launch of Verafit Sterilization Bags and Covers, which feature a new, patent-pending viewing window to visually inspect and confirm the dryness of a sterilized part. The unique design helps biopharmaceutical manufacturers conform to the latest EU GMP Annex 1 requirements for dryness confirmation as part of sterilization cycle acceptance.
“When EU GMP Annex 1 was released, we recognized that many of our Customers would need to visually confirm the dryness of a part within its sterile packaging,” said Elaine Sartain, Vice President, Global Marketing, STERIS Life Sciences Contamination Control Products. “Verafit Sterilization Bags and Covers make this possible via the viewing window. This enhancement adds to the overall value of our sterilization bags and covers, which provide an easy-to-use, consistent method of wrapping products and maintaining sterility.”
Verafit Sterilization Bags and Covers feature a polypropylene film window and are constructed with Purefit™ the cleanest flexible sterilization wrapping to reduce the risk of particulate, microbial, and chemical contamination per EU GMP Annex 1.
For more information about Verafit Sterilization Bags and Covers and other contamination control products and services from STERIS, please visit www.sterislifesciences.com.
About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services. Visit www.sterislifesciences.com for more information.
####
This news release may contain statements concerning certain expectations, forecasts, estimates, product performance or other forward-looking information affecting or relating to the Company or its products that are intended to qualify for the protections afforded "forward- looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," “new,” “advanced,” and “best available,” or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in this news release including, without limitation, disruption of production or supplies, changes in product use, pending or future claims, technology advances, and changes in government regulations or the application or interpretation thereof. No assurances can be provided as to any product performance or product safety unless all labeling, instructions for use, MSDS and other product literature are strictly followed. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in this news release include, without limitation, (a) the possibility that market demand will not develop for new technologies, products or application; (b) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent product introductions, affect the production and marketing of existing products, or otherwise affect product performance; or (c)uses not consistent with product instructions. Product descriptions and performances herein are for illustration only and do not modify labeling, warranties or other technical literature.
Media Contact:
Dan Lamb
+1 440-420-0987
Daniel_Lamb@steris.com